+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inhalation System"

From
US Inhalation Systems Market Forecast up to 2024 - Product Thumbnail Image

US Inhalation Systems Market Forecast up to 2024

  • Report
  • January 2019
  • 98 Pages
  • United States
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Inhalation System market is composed of two main categories: Inhalers and Nebulisers. Inhalers are devices that deliver medication directly to the lungs in the form of a mist or aerosol. They are typically used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Nebulisers are devices that convert liquid medication into a fine mist that can be inhaled. They are typically used to treat more severe respiratory conditions, such as cystic fibrosis. Inhalers and nebulisers are used in both hospital and home settings, and are available in a variety of forms, including metered dose inhalers, dry powder inhalers, and jet nebulisers. Inhalers and nebulisers are typically powered by either compressed air or electricity. Some of the major companies in the Inhalation System market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Philips Respironics. Show Less Read more